Recent Quotes (30 days)

You have no recent quotes
chg | %

Pharmaceutical Product Development Inc  

(Public, NASDAQ:PPDI)   Watch this stock  
Find more results for PPDI
0.0000
- Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield 0.15/∞T
EPS 1.43
Shares 113.69M
Beta     -
Inst. own 79%

Key stats and ratios

Q3 (Sep '11) 2010
Net profit margin 8.57% 8.66%
Operating margin 15.75% 12.41%
EBITD margin - 17.17%
Return on average assets 7.40% 6.33%
Return on average equity 11.98% 9.72%
Employees 11,000 -
Carbon Disclosure Rating - -

Address

929 North Front Street
WILMINGTON, NC 28401-3331
United States - Map
+1-910-2510081 (Phone)
+1-910-7625820 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Pharmaceutical Product Development, Inc, is a United States-based company, which provides drug discovery, development and lifecycle management services. Its Discovery Sciences segment offers preclinical program design, toxicology consulting, lab services, and technical writing and regulatory submissions, as well as compound collaboration programs. Its Development segment provides Phase 1 clinical testing, lab services, and Phases 2 through 4 clinical trial management services (such as study design, investigator recruitment, clinical data management and bio-statistical analysis). The Company's clients include pharmaceutical, biotechnology, medical device, academic and government organizations.